{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:33:00Z","timestamp":1761597180350},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,1,8]],"date-time":"2010-01-08T00:00:00Z","timestamp":1262908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s00702-009-0358-y","type":"journal-article","created":{"date-parts":[[2010,1,7]],"date-time":"2010-01-07T07:59:27Z","timestamp":1262851167000},"page":"377-383","source":"Crossref","is-referenced-by-count":14,"title":["BuChE K variant is decreased in Alzheimer\u2019s disease not in fronto-temporal dementia"],"prefix":"10.1007","volume":"117","author":[{"given":"Alessandra","family":"Bizzarro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Guglielmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Lomastro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Valenza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lauria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Marra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C.","family":"Silveri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. D.","family":"Tiziano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Brahe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Masullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,1,8]]},"reference":[{"key":"358_CR1","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/jmbi.1997.1245","volume":"272","author":"A Alvarez","year":"1997","unstructured":"Alvarez A, Opazo C, Alarc\u00f3n R, Garrido J, Inestrosa NC (1997) Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils. J Mol Biol 272:348\u2013361","journal-title":"J Mol Biol"},{"key":"358_CR2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1034\/j.1600-0404.2000.102006350.x","volume":"102","author":"A Alvarez-Arcaya","year":"2000","unstructured":"Alvarez-Arcaya A, Combarros O, Llorca J, S\u00e1nchez-Guerra M, Berciano J, Fern\u00e1ndez-Viadero C, Pe\u00f1a N (2000) The butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer\u2019s disease in women. Acta Neurol Scand 102:350\u2013353","journal-title":"Acta Neurol Scand"},{"key":"358_CR3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000084705","volume":"19","author":"C Ballard","year":"2005","unstructured":"Ballard C, Morris C, Kalaria R, McKeith I, Perry R, Perry E (2005) The K variant of the butyrylcholinesterase gene is associated with reduced phosphorylation of tau in dementia patients. Dement Geriatr Cogn Disord 19:357\u2013360","journal-title":"Dement Geriatr Cogn Disord"},{"key":"358_CR4","first-page":"1086","volume":"50","author":"CF Bartels","year":"1992","unstructured":"Bartels CF, Jensen FS, Lockridge O, van der Spek AF, Rubinstein HM, Lubrano T, La Du BN (1992) DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am J Hum Genet 50:1086\u20131103","journal-title":"Am J Hum Genet"},{"key":"358_CR5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1212\/WNL.48.1.139","volume":"48","author":"D Blacker","year":"1997","unstructured":"Blacker D, Haines JL, Rodes L, Terwedow H, Go RC, Harrell LE, Perry RT, Bassett SS, Chase G, Meyers D, Albert MS, Tanzi R (1997) ApoE-4 and age at onset of Alzheimer\u2019s disease: the NIMH genetics initiative. Neurology 48:139\u2013147","journal-title":"Neurology"},{"key":"358_CR6","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.fpc.0000220573.05714.ac","volume":"16","author":"R Blesa","year":"2006","unstructured":"Blesa R, Bullock R, He Y, Bergman H, Gambina G, Meyer J, Rapatz G, Nagel J, Lane R (2006) Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer\u2019s disease. Pharmacogenet Genomics 16:771\u2013774","journal-title":"Pharmacogenet Genomics"},{"key":"358_CR7","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s00415-006-0502-7","volume":"254","author":"O Combarros","year":"2007","unstructured":"Combarros O, Riancho JA, Arozamena J, Mateo I, Llorca J, Infante J, S\u00e1nchez-Juan P, Zarrabeitia MT, Berciano J (2007) Interaction between estrogen receptor-alpha and butyrylcholinesterase genes modulates Alzheimer\u2019s disease risk. J Neurol 254:1290\u20131292","journal-title":"J Neurol"},{"key":"358_CR8","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.nbd.2006.07.013","volume":"24","author":"T Darreh-Shori","year":"2006","unstructured":"Darreh-Shori T, Brimijoin S, Kadir A, Almkvist O, Nordberg A (2006) Differential CSF butyrylcholinesterase levels in Alzheimer\u2019s disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism. Neurobiol Dis 24:326\u2013333","journal-title":"Neurobiol Dis"},{"key":"358_CR9","unstructured":"Darreh-Shori T, Modiri N, Blennow K, Baza S, Kamil C, Ahmed H, Andreasen N, Nordberg A (2009) The apolipoprotein E varepsilon4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase. Neurobiol Aging (epub ahead of print)"},{"key":"358_CR10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cne.10751","volume":"463","author":"S Darvesh","year":"2003","unstructured":"Darvesh S, Hopkins DA (2003) Differential distribution of butyrylcholinesterase and acetylcholinesterase in the human talamus. J Comp Neurol 463:25\u201343","journal-title":"J Comp Neurol"},{"key":"358_CR11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2007.08.059","volume":"427","author":"MC D\u00e9niz-Naranjo","year":"2007","unstructured":"D\u00e9niz-Naranjo MC, Mu\u00f1oz-Fern\u00e1ndez C, Alemany-Rodr\u00edguez MJ, del Carmen P\u00e9rez-Vieitez M, Aladro-Benito Y, Irurita-Latasa J, S\u00e1nchez-Garc\u00eda F (2007) Butyrylcholinesterase. ApoE and Alzheimer\u2019s disease in a population from the Canary Islands (Spain). Neurosci Lett 427:34\u201338","journal-title":"Neurosci Lett"},{"key":"358_CR12","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.0602922103","volume":"103","author":"S Diamant","year":"2006","unstructured":"Diamant S, Podoly E, Friedler A, Ligumsky H, Livnah O, Soreq H (2006) Butyrylcholinesterase attenuates amyloid fibril formation in vitro. Proc Natl Acad Sci USA 103:8628\u20138633","journal-title":"Proc Natl Acad Sci USA"},{"key":"358_CR13","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1212\/WNL.46.6.1575","volume":"46","author":"R Duara","year":"1996","unstructured":"Duara R, Barker WW, Lopez-Alberola R, Loewenstein DA, Grau LB, Gilchrist D, Sevush S, St George-Hyslop S (1996) Alzheimer\u2019s disease: interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset. Neurology 46:1575\u20131579","journal-title":"Neurology"},{"key":"358_CR14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0306-4522(89)90399-0","volume":"33","author":"C Geula","year":"1989","unstructured":"Geula C, Mesulam M-M (1989) Cortical cholinergic fibres in aging and Alzheimer\u2019s Disease: a morphometric study. Neuroscience 33:469\u2013481","journal-title":"Neuroscience"},{"key":"358_CR15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(02)00014-9","volume":"320","author":"E Ghebremedhin","year":"2002","unstructured":"Ghebremedhin E, Thal DR, Schultz C, Braak H (2002) Age-dependent association between butyrylcholinesterase K-variant and Alzheimer Disease-related neuropathology in human brains. Neurosci Lett 320:25\u201328","journal-title":"Neurosci Lett"},{"key":"358_CR16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0006-8993(94)91852-X","volume":"640","author":"P G\u00f3mez-Ramos","year":"1994","unstructured":"G\u00f3mez-Ramos P, Bouras C, Mor\u00e1n MA (1994) Ultrastructural localization of butyrylcholinesterase on neurofibrillary degeneration sites in the brains of aged and Alzheimer\u2019s disease patients. Brain Res 640:17\u201324","journal-title":"Brain Res"},{"key":"358_CR17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0304-3940(99)00426-7","volume":"269","author":"JM Grubber","year":"1999","unstructured":"Grubber JM, Saunders AM, Crane-Gatherum AR, Scott WK, Martin ER, Haynes CS, Conneally PM, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1999) Analysis of association between Alzheimer disease and the K variant of butyrylcholinesterase (BCHE-K). Neurosci Lett 269:115\u2013119","journal-title":"Neurosci Lett"},{"key":"358_CR18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0304-3940(98)00453-4","volume":"250","author":"M Hiltunen","year":"1998","unstructured":"Hiltunen M, Mannermaa A, Helisalmi S, Koivisto A, Lehtovirta M, Ryynanen P Sr, Soininen H (1998) Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer\u2019s disease patients. Neurosci Lett 250:69\u201371","journal-title":"Neurosci Lett"},{"key":"358_CR19","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/jnnp.2004.039321","volume":"76","author":"C Holmes","year":"2005","unstructured":"Holmes C, Ballard C, Lehmann D, David Smith A, Beaumont H, Day IN, NadeemKhan M, Lovestone S, McCulley M, Morris CM, Munoz DG, O\u2019Brien K, Russ C, Del Ser T, Warden D (2005) Rate of progression of cognitive decline in Alzheimer\u2019s disease: effect of butyrylcholinesterase K gene variation. J Neurol Neurosurg Psychiatry 76:640\u2013643","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"358_CR20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1212\/01.wnl.0000191304.55196.4d","volume":"66","author":"ED Huey","year":"2006","unstructured":"Huey ED, Putnam KT, Grafman J (2006) A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia. Neurology 66:17\u201322","journal-title":"Neurology"},{"key":"358_CR21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000154321","volume":"46","author":"FS Jensen","year":"1996","unstructured":"Jensen FS, Nielsen LR, Schwartz M (1996) Detection of the plasma cholinesterase K variant by PCR using an amplification-created restriction site. Hum Hered 46:26\u201331","journal-title":"Hum Hered"},{"key":"358_CR22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/(SICI)1096-8628(19990416)88:2<113::AID-AJMG2>3.0.CO;2-3","volume":"88","author":"CS Ki","year":"1999","unstructured":"Ki CS, Na DL, Kim JW, Kim HJ, Kim DK, Yoon BK (1999) No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer\u2019s Disease. Am J Med Genet 88:113\u2013115","journal-title":"Am J Med Genet"},{"key":"358_CR23","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s007020170005","volume":"108","author":"KW Kim","year":"2001","unstructured":"Kim KW, Jhoo JH, Lee JH, Lee KU, Lee DY, Youn JC, Youn JY, Woo JI (2001) Neither the butyrylcholinesterase K variant nor transferrin C2 variant confers a risk for Alzheimer\u2019s Disease in Koreans. J Neural Transm 108:1159\u20131166","journal-title":"J Neural Transm"},{"key":"358_CR24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/(SICI)1096-8628(20000403)96:2<167::AID-AJMG8>3.0.CO;2-0","volume":"96","author":"DW Lee","year":"2000","unstructured":"Lee DW, Liu HC, Chi CW, Hong CJ (2000) No association between butyrylcholinesterase K-variant and Alzheimer Disease in Chinese. Am J Med Genet 96:167\u2013169","journal-title":"Am J Med Genet"},{"key":"358_CR25","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/hmg\/6.11.1933","volume":"6","author":"DJ Lehmann","year":"1997","unstructured":"Lehmann DJ, Johnston C, Smith AD (1997) Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer\u2019s Disease. Hum Mol Genet 6:1933\u20131936","journal-title":"Hum Mol Genet"},{"key":"358_CR26","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.nbd.2009.05.014","volume":"35","author":"W Maetzler","year":"2009","unstructured":"Maetzler W, Keller S, Michelis J, Koehler N, Stransky E, Becker C, Schulte C, Melms A, Gasser T, Berg D (2009) No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases. Neurobiol Dis 35:296\u2013301","journal-title":"Neurobiol Dis"},{"key":"358_CR27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1468-1331.2008.02059.x","volume":"15","author":"I Mateo","year":"2008","unstructured":"Mateo I, Llorca J, Infante J, Rodr\u00edguez-Rodr\u00edguez E, Berciano J, Combarros O (2008) Gene-gene interaction between 14-3-3 zeta and butyrylcholinesterase modulates Alzheimer\u2019s disease risk. Eur J Neurol 15:219\u2013222","journal-title":"Eur J Neurol"},{"key":"358_CR28","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/jmg.37.3.182","volume":"37","author":"SP McIlroy","year":"2000","unstructured":"McIlroy SP, Crawford VL, Dynan KB, McGleenon BM, Vahidassr MD, Lawson JT, Passmore AP (2000) Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer\u2019s disease in Northern Ireland. J Med Genet 37:182\u2013185","journal-title":"J Med Genet"},{"key":"358_CR29","first-page":"149","volume-title":"Butyrylcholinesterase: its function and inhibitors","author":"IG McKeith","year":"2003","unstructured":"McKeith IG, O\u2019Brien KK, Morris CM, Perry EK (2003) Butyrylcholinesterase and dementia with Lewy bodies: involvement in symptom progression and treatment response. In: Giacobini E (ed) Butyrylcholinesterase: its function and inhibitors. Martin Dunitz, London, pp 149\u2013162"},{"key":"358_CR30","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical Diagnosis of Alzheimer\u2019s Disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 34:939\u2013944","journal-title":"Neurology"},{"key":"358_CR31","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/ana.410360506","volume":"36","author":"M Mesulam","year":"1994","unstructured":"Mesulam M, Geula C (1994) Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia. Ann Neurol 36:722\u2013727","journal-title":"Ann Neurol"},{"key":"358_CR32","first-page":"391","volume":"5","author":"R Mullenbach","year":"1989","unstructured":"Mullenbach R, Lagoda PJ, Welter C (1989) An efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet 5:391","journal-title":"Trends Genet"},{"key":"358_CR33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jnnp.51.3.353","volume":"51","author":"D Neary","year":"1988","unstructured":"Neary D, Snowden JS, Northern B, Goulding P (1988) Dementia of frontal lobe type. J Neurol Neurosurg Psychiatry 51:353\u2013361","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"358_CR34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00008571-200304000-00008","volume":"13","author":"KK O\u2019Brien","year":"2003","unstructured":"O\u2019Brien KK, Saxby BK, Ballard CG, Grace J, Harrington F, Ford GA, O\u2019Brien JT, Swan AG, Fairbairn AF, Wesnes K, del Ser T, Edwardson JA, Morris CM, McKeith IG (2003) Regulation of attention and response to therapy in dementia by butyrylcholinesterase. Pharmacogenetics 13:231\u2013239","journal-title":"Pharmacogenetics"},{"key":"358_CR35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s004150050365","volume":"246","author":"PK Panegyres","year":"1999","unstructured":"Panegyres PK, Mamotte CD, Vasikaran SD, Wilton S, Fabian V, Kakulas BA (1999) Butyrycholinesterase K variant and Alzheimer\u2019s disease. J Neurol 246:369\u2013370","journal-title":"J Neurol"},{"key":"358_CR36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2990.1978.tb00545.x","volume":"4","author":"EK Perry","year":"1978","unstructured":"Perry EK, Perry RH, Blessed G, Tomlinson BE (1978) Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol Appl Neurobiol 4:273\u2013277","journal-title":"Neuropathol Appl Neurobiol"},{"key":"358_CR37","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ajmg.b.30548","volume":"144B","author":"M Piccardi","year":"2007","unstructured":"Piccardi M, Congiu D, Squassina A, Manconi F, Putzu FP, Mereu RM, Chillotti C, Del Zompo M (2007) Alzheimer disease: Case-control association study of polymorphisms in ACHE, CHAT, and BCHE genes in a Sardinian sample. Am J Med Genet 144B:895\u2013899","journal-title":"Am J Med Genet"},{"key":"358_CR38","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000113711","volume":"5","author":"E Podoly","year":"2008","unstructured":"Podoly E, Bruck T, Diamant S, Melamed-Book N, Weiss A, Huang Y, Livnah O, Langermann S, Wilgus H, Soreq H (2008) Human recombinant butyrylcholinesterase purified from the milk of transgenic goats interacts with beta-amyloid fibrils and suppresses their formation in vitro. Neurodegener Dis 5:232\u2013236","journal-title":"Neurodegener Dis"},{"key":"358_CR39","doi-asserted-by":"crossref","first-page":"17170","DOI":"10.1074\/jbc.M109.004952","volume":"284","author":"E Podoly","year":"2009","unstructured":"Podoly E, Shalev DE, Shenhar-Tsarfaty S, Bennett ER, Ben Assayag E, Wilgus H, Livnah O, Soreq H (2009) The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology. J Biol Chem 284:17170\u201317179","journal-title":"J Biol Chem"},{"key":"358_CR40","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neulet.2004.08.057","volume":"371","author":"AV Raygani","year":"2004","unstructured":"Raygani AV, Zahrai M, Soltanzadeh A, Doosti M, Javadi E, Pourmotabbed T (2004) Analysis of association between Butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer\u2019s Disease. Neurosci Lett 371:142\u2013146","journal-title":"Neurosci Lett"},{"key":"358_CR41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0304-3940(95)12190-0","volume":"201","author":"R Scacchi","year":"1995","unstructured":"Scacchi R, De Bernardini L, Mantuano E, Donini LM, Vilardo T, Corbo RM (1995) Apolipoprotein E (APOE) allele frequencies in late-onset sporadic Alzheimer\u2019s disease (AD), mixed dementia and vascular dementia: lack of association of epsilon 4 allele with AD in Italian octogenarian patients. Neurosci Lett 201:231\u2013234","journal-title":"Neurosci Lett"},{"key":"358_CR42","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ajmg.b.30846","volume":"150B","author":"R Scacchi","year":"2008","unstructured":"Scacchi R, Gambina G, Moretto G, Corbo RM (2008) Variability of AChE, BChE, and ChAT genes in the late-onset form of Alzheimer\u2019s disease and relationships with response to treatment with Donepezil and Rivastigmine. Am J Med Genet B Neuropsychiatr Genet 150B:502\u2013507","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"358_CR43","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/hmg\/7.5.937","volume":"7","author":"AB Singleton","year":"1998","unstructured":"Singleton AB, Smith G, Gibson AM, Woodward R, Perry RH, Ince PG, Edwardson JA, Morris CM (1998) No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer\u2019s Disease. Hum Mol Genet 7:937\u2013939","journal-title":"Hum Mol Genet"},{"key":"358_CR44","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/jnnp.67.5.693","volume":"67","author":"N Sodeyama","year":"1999","unstructured":"Sodeyama N, Yamada M, Itoh Y, Otomo E, Suematsu N, Matsushita M (1999) Association between butyrylcholinesterase K variant and the Alzheimer type neuropathological changes in apolipoprotein E epsilon4 carriers older than 75\u00a0years. J Neurol Neurosurg Psychiatry 67:693\u2013694","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"358_CR45","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.ejhg.5200351","volume":"7","author":"L Tilley","year":"1999","unstructured":"Tilley L, Morgan K, Grainger J, Marsters P, Morgan L, Lowe J, Xuereb J, Wischik C, Harrington C, Kalsheker N (1999) Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer\u2019s disease. Eur J Hum Genet 7:659\u2013663","journal-title":"Eur J Hum Genet"},{"key":"358_CR46","first-page":"1158","volume":"337","author":"PR Whenam","year":"1991","unstructured":"Whenam PR, Price WH, Blandell G (1991) Apolipoprotein E genotyping by one-stage PCR. Lancet 337:1158\u20131159","journal-title":"Lancet"},{"key":"358_CR47","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s004390050929","volume":"104","author":"H Wiebusch","year":"1999","unstructured":"Wiebusch H, Poirier J, S\u00e9vigny P, Schappert K (1999) Further evidence for a synergistic association between APOE e4 and BCHE-K in confirmed Alzheimer\u2019s Disease. Human Genet 104:158\u2013163","journal-title":"Human Genet"},{"key":"358_CR48","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/jnnp.67.1.94","volume":"67","author":"Y Yamamoto","year":"1999","unstructured":"Yamamoto Y, Yasuda M, Mori E, Maeda K (1999) Failure to confirm a synergistic effect between the K-variant of the butyrylcholinesterase gene and the e4 allele of the apolipoprotein gene in Japanese patients with Alzheimer\u2019s Disease. J Neurol Neurosurg Psychiatry 67:94\u201396","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-009-0358-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-009-0358-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-009-0358-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:25:17Z","timestamp":1559103917000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-009-0358-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,8]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["358"],"URL":"https:\/\/doi.org\/10.1007\/s00702-009-0358-y","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,8]]}}}